-+ 0.00%
-+ 0.00%
-+ 0.00%

IDORSIA LTD - PHASE 3 STUDY OF DARIDOREXANT SHOWS THAT 50 MG IMPROVED BOTH SLEEP AND DAYTIME FUNCTIONING COMPARED TO PLACEBO IN WOMEN DURING MENOPAUSAL TRANSITION AGE

Reuters·01/05/2026 16:46:13

Please log in to view news